Amanote Research
Register
Sign In
Reduction in the Frequency of Transplant-Related Complications in Patients With Chronic Myeloid Leukemia Undergoing BMT Preconditioned With a New, Non-Myeloablative Drug Combination
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1701167
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
April 1, 1998
Authors
E Kelemen
T Masszi
P Reményi
A Barta
K Pálóczi
Publisher
Springer Science and Business Media LLC
Related search
Do Minitransplants Have Minicosts? A Cost Comparison Between Myeloablative and Nonmyeloablative Allogeneic Stem Cell Transplant in Patients With Acute Myeloid Leukemia
Bone Marrow Transplantation
Transplantation
Hematology
Leukemia Cutis in a Patient With Chronic Myeloid Leukemia
IOSR Journal of Dental and Medical Sciences
Cost of Disease Progression in Patients With Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
The Influence of Stem Cell Source on Chronic-GvHD Free, Leukemia Free Transplant Survival in Pediatric Patients With Acute Myeloid Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia
Oncology and Therapy
Oncology
A Prisoner With Chronic Myeloid Leukemia
Bone Marrow Transplantation
Transplantation
Hematology
Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
SOX30 Methylation Correlates With Disease Progression in Patients With Chronic Myeloid Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
